Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 5:42 PM ET


Company Overview of Pharnext SAS

Executive Profile

Daniel E. Cohen M.D., Ph.D.

Co-Founder, Chairman and Chief Executive Officer, Pharnext SAS
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Daniel E. Cohen, MD, PhD served as the Chief Scientific Officer of Serono Genetics Institute S.A. Dr. Cohen is the Founder of CNS Inc. He is a Co-Founder of Millennium Pharmaceuticals, Inc., and Pharnext SAS. He serves as Chairman and Chief Executive Officer Pharnext SAS. Dr. Cohen is the Founder of modern genetics, genomics and pharmacogenomics. He joined Serono Genetics Institute S.A. in 1996 as Chief Genomics Officer and Directeur Général. He served as the Chief ...

Corporate Headquarters

Pépinière Santé Cochin
Paris, Ile-de-France 75014


Phone: 33 1 55 42 62 00
Fax: 33 1 55 42 62 01

Board Members Memberships

Co-Founder, Chairman and Chief Executive Officer


Université Denis Diderot - Paris VII
Université Denis Diderot - Paris VII
Honorary Doctorate
Shanghai University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pharnext SAS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at